Odontoprev S.A

What it is

Odontoprev was founded in 1987 and grew into Latin America’s largest dental benefits company, holding over 25% market share. It sells dental cover to large companies, small businesses, and individuals, then pays a network of some 27,000 dentists to treat those members.

Odontoprev is the clear market leader, with over 1.5 million more beneficiaries than its closest rival; it is unique in being 100% focused on dental, while most competitors offer both medical and dental insurance. That narrow focus keeps costs low and margins high.

Who owns it

The decisive turn came in 2009, when Bradesco Saúde acquired a 43.5% stake; by 2013, Bradesco had increased that holding enough to assume outright control. Today Bradesco owns roughly 53% of the shares — a figure that is about to rise sharply.

Once the current restructuring is complete, Bradesco’s stake will reach 91.35% of the total and voting capital, leaving existing minority shareholders with 8.65%. Odontoprev will simultaneously be renamed Bradsaúde and transformed into a holding company for Bradesco’s entire healthcare ecosystem.

The remaining ~32% held by institutions and the roughly 40,000 smaller shareholders flows into that residual free float.

Who runs it

In August 2024, Rodrigo Bacellar Wuerkert resigned as CEO, with Elsen Carvalho — previously the Commercial Officer — assuming the top role. Carvalho joined Odontoprev in 2017 as Commercial Director after a career at investment banks and retail companies, and assumed the CEO role in 2024.

The CFO and Investor Relations Officer is José Roberto Borges Pacheco, who has held the position since 2019 and also serves as Director of Market Relations at the Bradesco insurance holding, Bradseg. Board chairman is Luiz Carlos Trabuco Cappi, the former long-serving CEO of Banco Bradesco itself — a signal of how central Odontoprev has become to the group’s ambitions.

The money, in plain words

Revenue has grown steadily — R$2.12bn (US$412 mn) in 2023, R$2.28bn (US$443 mn) in 2024, R$2.42bn (US$470 mn) in fiscal 2025 — gains of 7.7% then 6.1% year on year (our calculation). The company keeps about 23 cents of profit from every real of sales — a net margin of 22.9%, exceptional for an insurer — because it needs almost no physical assets to operate.

For every real its owners have put in, Odontoprev earns back nearly 46 cents a year — a return on equity of 46.4%, well above any peer benchmark. It is effectively debt-free with low capital-spending needs, and prioritises returning cash to shareholders.

For the second quarter of 2025, dividends of R$115m (US$22 mn) were approved, up 35% year-on-year; since its 2006 IPO, the company has distributed over R$3.8bn (US$738 mn) in dividends and interest on capital.

What it is doing now

Banco Bradesco has unveiled a sweeping reorganisation — using Odontoprev as the listed vehicle — to create “Bradsaúde,” a consolidated healthcare platform set to debut with R$52bn (US$10.1 bn) in revenue, R$3.6bn (US$699 mn) in net profit, and a 24% return on equity based on combined 2025 figures. The resulting group will serve more than 13 million beneficiaries and include some 3,600 contracted hospital beds and 35 primary-care clinics.

Shareholders of Odontoprev and Bradesco Gestão de Saúde approved the first merger steps on 6 April 2026; Brazil’s health regulator had already cleared the structure in late March and early April 2026. The deal is at its final closing stages at the time of writing.

What to watch

• The Bradsaúde transition. The transaction remains subject to final closing conditions, including shareholder and regulatory approvals. Any delay or renegotiation of the minority exchange ratio could move the share price sharply.
• Minority dilution maths. Minority shareholders will hold 8.65% of the new company; applied to the 2025 results of the entire Bradesco health ecosystem, that implies about 20% growth in earnings per share — but only if the integration delivers its promised gains.
• Dividend continuity. The 5.4% yield rests on a payout policy that may shift once Odontoprev becomes a pure holding company inside a much larger structure.
• Market penetration room. Brazil has more than twice as many dentists as the United States yet far fewer private dental insurance plans relative to medical ones — the runway remains long, whoever ultimately owns the platform.

This is news, not investment advice.